# Continuous TQL Block for Elective Cesarean Section

> **NCT03663478** · PHASE4 · COMPLETED · sponsor: **Zealand University Hospital** · enrollment: 32 (actual)

## Conditions studied

- Postoperative Pain
- Anesthesia, Local

## Interventions

- **DRUG:** Ropivacaine
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT03663478
- **Lead sponsor:** Zealand University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-04
- **Primary completion:** 2020-04-08
- **Final completion:** 2020-04-08
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2021-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03663478

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03663478, "Continuous TQL Block for Elective Cesarean Section". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03663478. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*